Search Results

You searched for : Sandoz

	Aurobindo Pharma acquires Veritaz Drugmaker Aurobindo Pharma will acquire domestic formulation company Veritaz for Rs 171 crore in a cash-free and debt-free way. ... Mar 29
	Sandoz completes acquisition of GSKâ€™s cephalosporin business, reinforcing leading global position in antibiotics Latest Pharma news update... Oct 12
	Novartis announces collaboration with Molecular Partners to develop two DARPinÂ® therapies designed for potential use against COVID-19 Novartis and Molecular Partners AG today announced a collaboration to develop two DARPinÂ® therapies designed for potential use against COVID-19... Oct 28
	Collaboration between Novartis and Africa Medical Supplies : COVID-19 Update 15 generic and over-the-counter (OTC) medicines from Sandoz division will be sold at zero-profit to governments ... Sep 02
	Novartis to make no profit on 15 drugs to treat COVID-19 symptoms Medicines will be sold at zero-profit to governments in up to 791 eligible countries during the pandemic and until a vaccine or curative treatment ... Jul 17
	$900 million deal called off by Aurobindo, Sandoz In September 2018, Aurobindo Pharma had said its US subsidiary has entered into a pact to acquire commercial operations and three manufacturing facilities in America ... Apr 03
	Novartis CEO says hydroxychloroquine is the company's biggest hope Other companies including Bayer and Teva have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences is testing its experimental drug remdesivir against ... Apr 02
	Biocon attracts Rs 536.25 crore from True North for a 2.44% minority stake True North to invest 536.24 crores in Biocon for 2.44% minority stake... Jan 07
	Polpharma Biologics Announces Global Commercialization Deal for Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine Polpharma Biologics S.A. ("Polpharma Biologics") today announces that it has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar. The medicine ... Sep 13
	Polpharma Biologics Announces Global Commercialization Deal for Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine Polpharma Biologics S.A. ("Polpharma Biologics") today announces that it has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar. The medicine ... Sep 05
10 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Aurobindo Pharma acquires Veritaz

Sandoz completes acquisition of GSKâ€™s cephalosporin business, reinforcing leading global position in antibiotics

Novartis announces collaboration with Molecular Partners to develop two DARPinÂ® therapies designed for potential use against COVID-19

Collaboration between Novartis and Africa Medical Supplies : COVID-19 Update

Novartis to make no profit on 15 drugs to treat COVID-19 symptoms

$900 million deal called off by Aurobindo, Sandoz

Novartis CEO says hydroxychloroquine is the company's biggest hope

Biocon attracts Rs 536.25 crore from True North for a 2.44% minority stake

Polpharma Biologics Announces Global Commercialization Deal for Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine

Polpharma Biologics Announces Global Commercialization Deal for Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine

Trending Now